Remote diagnostic platforms to simulate the Europe Urethral Bulking Systems Market at a CAGR of 6%

The Europe urethral bulking systems market was valued US$ 21.2 Mn in 2020, and is expected to accelerate at a decent CAGR of approximately 6% over the forecast period (2021-2031), with most of the growth of the market being driven by procedures at hospitals across the European continent.

The Europe urethral bulking systems market is expected to witness significant growth in the coming years due to the increasing prevalence of SUI and the aging population in the region. In addition, the increasing awareness about SUI treatment options and the availability of new and advanced urethral bulking systems are also driving market growth.

Increase in female geriatric population is one of the major driving factors for the market in Europe. According to the Statistical Office of the European Union (Eurostat), 20.6% of the EU population was aged 65 and over in 2020. This creates opportunity for market players to grow in the region over the coming years.

The Europe urethral bulking systems market can be segmented into two main categories: injectable bulking agents and implantable bulking systems. Injectable bulking agents are injected directly into the urethra to add volume and support to the urethral walls. Implantable bulking systems are small, permanent implants that are placed in the urethra to add volume and support to the urethral walls.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32668

The Europe urethral bulking systems market is expected to witness significant growth in the Western Europe region due to the increasing prevalence of SUI and the aging population in the region. In addition, the increasing awareness about SUI treatment options and the availability of new and advanced urethral bulking systems are also driving market growth in the region.

In conclusion, the Europe urethral bulking systems market is expected to witness significant growth in the coming years due to the increasing prevalence of SUI and the aging population in the region. The increasing awareness about SUI treatment options and the availability of new and advanced urethral bulking systems are also driving market growth. The Western Europe region is expected to be a key growth driver for the market due to the increasing prevalence of SUI and the aging population in the region.

Company Profiles:

Boston Scientific Corporation
Coloplast Corporation
Axonics Modulation Technologies, Inc. (Contura, Inc.)
Palette Life Sciences, Inc.
Laborie, Inc.

Key Takeaways from Market Study

By product, pyrolytic carbon-coated graphite beads to hold over half value share of the overall market.

Based on end user, hospitals is the leading segment with 67.5% of the market share in Europe.
Germany dominates the urethral bulking systems market in Europe with a value share of over 20% in 2020, and will continue to hold a dominant position over the next ten years as well.

The COVID-19 pandemic affected market growth negatively in 2020, dropping the year-on-year growth from 6.5% to 5.9% from the previous year.
"Although pyrolytic carbon-coated graphite bead-based urethral bulking systems are expected to create lucrative opportunities for market players, demand for polyacrylamide hydrogel is expected to increase at a higher CAGR," says an analyst of Persistence Market Research.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/32668

Increasing efforts by manufacturers to create awareness and help urological professionals and patients through special educational sessions are expected to aid market growth during the forecast period. Key manufacturers are focusing on carrying out acquisitions that will broaden their product portfolios and help in expanding their presence in the market. Additionally, manufacturers are also focusing on entering into strategic partnerships with other companies to develop innovative products in the field of urology.

In February 2019, Coloplast Group entered into an agreement with Premier, Inc. for three years to purchase its general urological products.
In September 2020, Palette Life Sciences announced a partnership agreement with EVERSANA in order to support the commercialization in the U.S.

Buy Full Report Now and Get Upto 20% Discount @ https://www.persistencemarketresearch.com/checkout/32668

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the urethral bulking systems market in its latest study, presenting a historical demand assessment of 2016 - 2020 and projections for 2021 - 2031.

The research study is based on the product (pyrolytic carbon-coated graphite beads, calcium hydroxylapatite-based, polydimethylsiloxane macroparticle, polyacrylamide hydrogel, and hyaluronic acid-based) and end user (hospitals, ambulatory surgical centers, and specialty clinics), across the countries of Europe.

Know More:
https://www.medgadget.com/2021/09/the-europe-urethral-bulking-systems-market-to-stick-to-technological-upgradations-at-a-cagr-of-6-between-2021-2031.html

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About Us:

Persistence Market Research's Expertise in Life Sciences and Transformational Health
Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations. Click here to learn more about how we zero in on the critical aspects of this industry.

This release was published on openPR.